List of works by Chris Wilkins

"You have to make some money before you can do some good": Balancing the commercial, social and public health objectives in a "community enterprise" regulatory model for alcohol and cannabis

scientific article published on 08 February 2020

A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand

scientific article published on 12 January 2018

A 'demand side' estimate of the dollar value of the cannabis black market in New Zealand

scientific article published on June 2002

A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand.

scientific article published on 7 March 2018

A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand.

scientific article

A paradigm shift in recreational drug use: the challenge of legal highs in New Zealand.

scientific article

A pilot study of a computer-assisted cell-phone interview (CACI) methodology to survey respondents in households without telephones about alcohol use.

scientific article

After the legalisation of cannabis: the Cannabis Incorporated Society (CIS) regulatory model for recreational cannabis in New Zealand.

scientific article published on 22 April 2016

An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland

scientific article

An exploratory wastewater analysis study of drug use in Auckland, New Zealand.

scientific article published on 12 March 2017

Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand

scientific article

Assessment of drugs of abuse in a wastewater treatment plant with parallel secondary wastewater treatment train

scientific article published on 14 December 2018

Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand.

scientific article published in July 2005

Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE)

article

Consumer agency in cannabis supply - Exploring auto-regulatory documents of the cannabis social clubs in Spain.

scientific article published on 18 January 2018

Criminal justice outcomes for cannabis use offences in New Zealand, 1991-2008

scientific article published on 20 April 2012

Determinants of the retail price of illegal drugs in New Zealand

scientific article published on 10 April 2020

Did we have the wrong debate about Elixinol™ and medicinal cannabis?

scientific article published on 04 September 2015

Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?

scientific article published on 8 April 2009

Do police arrestees substitute legal highs for other drugs?

scientific article published on 18 January 2016

Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.

scientific article published on 4 April 2003

Estimating the dollar value of the illicit market for cannabis in New Zealand.

scientific article published in May 2005

Examining the blurred boundaries between medical and recreational cannabis – results from an international study of small-scale cannabis cultivators

Individual dollar expenditure and earnings from cannabis in the New Zealand population

scientific article published on 13 December 2006

Investigating the New Zealand policy response to methamphetamine-contaminated houses

scientific article published on 26 February 2020

Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for 'low-risk' psychoactive products in New Zealand?

scientific article published in April 2015

Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.

scientific article

Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand

scientific article

Legal piperazine-containing party pills--a new trend in substance misuse

scientific article published on May 2007

Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.

scientific article published on 13 December 2014

Medicinal Cannabis Scheme in New Zealand: lessons from international experience and our own recent drug policy reform setbacks

scientific article published on 04 October 2019

New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?

scientific article published on 20 March 2019

Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey

scientific article published on 12 March 2004

Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand

scientific article published in November 2008

Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010-2015.

scientific article published on 23 April 2017

Recent developments with the New Zealand regulated market approach to 'low-risk' psychoactive products.

scientific article published on 26 July 2016

Recent developments with the establishment of a regulated legal market for new psychoactive substances ('legal highs') in New Zealand

scientific article published on 10 October 2014

Recent population trends in amphetamine use in New Zealand: comparisons of findings from national household drug surveying in 1998, 2001, and 2003

scientific article published on 27 October 2006

Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009

scientific article published on 01 May 2011

Reply to Sumnall (2013), 'The New Zealand new psychoactive substances regime--a step in the right direction, but questions still remain'.

scientific article published in November 2013

Responding to a new wave of high potency synthetic cannabinoids

scientific article published on 21 September 2018

Response to commentaries.

scientific article published in October 2014

School autonomy reform in Queensland: governance, freedom and the entrepreneurial leader

scholarly article by Amanda Keddie et al published 5 December 2017 in School Leadership and Management

Smoke in our eyes: the Sense Partners' evaluation of the legalisation of cannabis in New Zealand

scientific article published on 22 February 2019

The association between spending on methamphetamine/amphetamine and cannabis for personal use and earnings from acquisitive crime among police detainees in New Zealand

scientific article

The case for medicinal cannabis: where there is smoke there may well be fire

scientific article published on 18 November 2016

The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution

scientific article published on 20 August 2015

The effectiveness of cannabis crop eradication operations in New Zealand

scientific article published on December 2002

The emergence of amphetamine use in New Zealand: findings from the 1998 and 2001 National Drug Surveys

scientific article

The impact of the prohibition of benzylpiperazine (BZP) "legal highs" on the availability, price and strength of BZP in New Zealand.

scientific article published in August 2014

The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand

scientific article published on 20 July 2012

The interim regulated legal market for NPS ('legal high') products in New Zealand: The impact of new retail restrictions and product licensing

scientific article published on 12 May 2014

The new psychoactive substances regime in New Zealand: a different approach to regulation

article

Thirty-one psychoactive plants exempted from New Zealand's Psychoactive Substances Act 2013.

scientific article published on 23 August 2016

Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.

scientific article published on 23 May 2008

Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory

scientific article published on 08 June 2018

What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties

article

“Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand

article

Paulina is supported by:

About Paulina

Help